Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

Bibliographic Details
Main Authors: Xiaoge Gao, Pin Jiang, Xiaohuan Wei, Wei Zhang, Jiwei Zheng, Shishuo Sun, Hong Yao, Xiangye Liu, Qing Zhang
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Cancer
Online Access:https://doi.org/10.1186/s12885-023-10843-0
_version_ 1827961262343979008
author Xiaoge Gao
Pin Jiang
Xiaohuan Wei
Wei Zhang
Jiwei Zheng
Shishuo Sun
Hong Yao
Xiangye Liu
Qing Zhang
author_facet Xiaoge Gao
Pin Jiang
Xiaohuan Wei
Wei Zhang
Jiwei Zheng
Shishuo Sun
Hong Yao
Xiangye Liu
Qing Zhang
author_sort Xiaoge Gao
collection DOAJ
first_indexed 2024-04-09T16:23:50Z
format Article
id doaj.art-582f4b38f9264b64b025bda385a743d8
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-09T16:23:50Z
publishDate 2023-04-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-582f4b38f9264b64b025bda385a743d82023-04-23T11:20:17ZengBMCBMC Cancer1471-24072023-04-012311310.1186/s12885-023-10843-0Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicityXiaoge Gao0Pin Jiang1Xiaohuan Wei2Wei Zhang3Jiwei Zheng4Shishuo Sun5Hong Yao6Xiangye Liu7Qing Zhang8Cancer Institute, Xuzhou Medical UniversityCancer Institute, Xuzhou Medical UniversityCancer Institute, Xuzhou Medical UniversityCancer Institute, Xuzhou Medical UniversityDepartment of Oral Medicine, School of Stomatology, Xuzhou Medical UniversityCancer Institute, Xuzhou Medical UniversityCancer Institute, Xuzhou Medical UniversityDepartment of Pathogenic Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Xuzhou Medical UniversityCancer Institute, Xuzhou Medical Universityhttps://doi.org/10.1186/s12885-023-10843-0
spellingShingle Xiaoge Gao
Pin Jiang
Xiaohuan Wei
Wei Zhang
Jiwei Zheng
Shishuo Sun
Hong Yao
Xiangye Liu
Qing Zhang
Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
BMC Cancer
title Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
title_full Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
title_fullStr Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
title_full_unstemmed Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
title_short Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
title_sort correction novel fusion protein pk5 rl gal 3 c inhibits hepatocellular carcinoma via anti angiogenesis and cytotoxicity
url https://doi.org/10.1186/s12885-023-10843-0
work_keys_str_mv AT xiaogegao correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT pinjiang correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT xiaohuanwei correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT weizhang correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT jiweizheng correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT shishuosun correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT hongyao correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT xiangyeliu correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity
AT qingzhang correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity